C18ORF32 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.450200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.539600E-01
Normal-vs-Stage2
1.765640E-01
Normal-vs-Stage3
2.368400E-01
Normal-vs-Stage4
6.808000E-01
Stage1-vs-Stage2
1.296240E-01
Stage1-vs-Stage3
3.743600E-01
Stage1-vs-Stage4
7.505600E-01
Stage2-vs-Stage3
9.796200E-01
Stage2-vs-Stage4
4.973200E-01
Stage3-vs-Stage4
6.947400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.696000E-01
Normal-vs-AfricanAmerican
8.258600E-01
Normal-vs-Asian
2.876100E-02
Caucasian-vs-AfricanAmerican
4.283400E-01
Caucasian-vs-Asian
2.040300E-02
AfricanAmerican-vs-Asian
1.290370E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.266200E-01
Normal-vs-Female
6.197200E-01
Male-vs-Female
7.850400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.891400E-01
Normal-vs-Age(41-60Yrs)
7.814400E-01
Normal-vs-Age(61-80Yrs)
3.024600E-01
Normal-vs-Age(81-100Yrs)
1.388970E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.849400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.559400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.838200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.144200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.634400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.560600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.434100E-02
Normal-vs-Daily Drinker
4.799200E-01
Normal-vs-Weekly Drinker
3.895700E-02
Normal-vs-Occasional Drinker
9.622000E-01
Normal-vs-Social Drinker
8.303800E-01
Non Drinker-vs-Daily Drinker
3.718000E-01
Non Drinker-vs-Weekly Drinker
7.795000E-01
Non Drinker-vs-Occasional Drinker
2.782500E-02
Non Drinker-vs-Social Drinker
1.826440E-01
Daily Drinker-vs-Weekly Drinker
3.154200E-01
Daily Drinker-vs-Occasional Drinker
1.818970E-01
Daily Drinker-vs-Social Drinker
4.867200E-01
Weekly Drinker-vs-Occasional Drinker
2.455700E-02
Weekly Drinker-vs-Social Drinker
1.588570E-01
Occasional Drinker-vs-Social Drinker
6.405000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.671550E-01
Normal-vs-Grade 2
3.863900E-02
Normal-vs-Grade 3
9.730300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.255950E-02
Grade 1-vs-Grade 3
8.137400E-03
Grade 1-vs-Grade 4
1.671550E-01
Grade 2-vs-Grade 3
5.060800E-01
Grade 2-vs-Grade 4
3.863900E-02
Grade 3-vs-Grade 4
9.730300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.315250E-01
Normal-vs-NonDiabetic
5.085800E-01
Diabetic-vs-NonDiabetic
7.852300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.265610E-02
Normal-vs-NoPancreatitis
4.112200E-01
Pancreatitis-vs-NoPancreatitis
1.349590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.660200E-01
Normal-vs-N1
2.108200E-01
N0-vs-N1
1.032180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.187210E-01
Normal-vs-TP53-NonMutant
8.590000E-01
TP53-Mutant-vs-TP53-NonMutant
3.077100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
